Robert Copeland

Robert Copeland

Company: Accent Therapeutics

Job title: President & Chief Scientific Officer

Seminars:

Live Panel Q&A – Ask the Speakers your Burning Questions 3:40 pm

Read more

day: Day Two

Targeting RNA-Modifying Proteins for Precision Cancer Therapeutics 3:00 pm

• RNA modifications control many aspects of RNA biology, including translation • Dysregulation of gene transcription and translation control mechanisms is common in cancer • Accent is targeting selective RNA modifying proteins for specific cancer indicationsRead more

day: Day Two

© Copyright 2018 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.